Skip to main content
Clinical Trials/CTRI/2024/03/064873
CTRI/2024/03/064873
Not yet recruiting
Phase 2

The efficacy and safety of injectable platelet rich fibrin (PRF) therapy and topical minoxidil (5%) fortified with finasteride (0.1%) in the treatment of androgenetic alopecia

Dr Rajendra Prasad Medical College Kangar at Tanda0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Rajendra Prasad Medical College Kangar at Tanda
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Rajendra Prasad Medical College Kangar at Tanda

Eligibility Criteria

Inclusion Criteria

  • Age group 18\-50 years
  • Presenting with patterned hair loss
  • Males \- norwood hamilton grade 3,4,5
  • Patients who have not taken medical treatment for aga in any form for the last 6 months

Exclusion Criteria

  • Patients with alopecia other than androgenetic alopecia
  • Patient with active infection at the local site
  • Patient have keloidal tendency
  • Patient with blood coagulopathies
  • Platelet count less than 1\.5 lac/ul
  • Patients who are immunocompromised(hiv, malignancy, steroid or chemotherapy)

Outcomes

Primary Outcomes

Not specified

Similar Trials